RXRα represents an intriguing and unique target for pharmacologic interventions. We recently showed that Sulindac and a designed analog could bind to RXRα and modulate its biological activity, including inhibition of the interaction of an N-terminally truncated RXRα (tRXRα) with the p85α regulatory subunit of phosphatidylinositol-3-OH kinase (PI3K). Here we report the synthesis, testing and SAR of a series of novel analogs of Sulindac as potential modulators for inhibiting tRXRα-dependent AKT activation. A new compound 30 was identified to have improved biological activity.
Introduction
Retinoid X receptor-α (RXRα) is a unique member of the nuclear receptor (NR) superfamily, playing an important role in many biological processes ranging from apoptosis, cell differentiation and growth to lipid metabolism [1] [2] [3] . RXRα acts primarily as a liganddependent transcription factor through forming homodimer with itself or heterodimer with other members of the NR family. Structurally RXRα shares a modular organization with other nuclear receptors, consisting of three main functional domains: an N-terminal region where the ligand-independent transcriptional activation function (AF-1) is located, a DNAbinding domain and a ligand-binding domain (LBD) [2] . The transcriptional activity is directly mediated by the LBD and thus the LBD has been the most studied domain. The LBD possesses a ligand-binding pocket (LBP) for the binding of small molecule ligands, a transactivation function domain termed AF-2 composed of Helix 12 (H12) of the LBD, a coregulator binding surface, and a dimerization surface. Numerous ligands targeting the
Conclusion
In conclusion, we have described the synthesis and SAR studies on a series of novel analogs of Sulindac as potential modulators for inhibiting tRXRα-dependent AKT activation. Compound 30, a geometric isomer of the original lead 2 and with better binding activity and improved biological effects, could bind to the LBP of RXRα in a different mode from 2, which offers a new design strategy. 30 is a promising lead for further optimization studies and may find application as a small molecule probe in studying the mechanism of the tRXRα-dependent AKT signaling.
Experimental section
5.1. Chemistry 5.1.1. General methods-Melting points (M.p.) were determined on a Yanaco MP-500 micro melting point apparatus and were uncorrected. Infrared spectra were measured with a Nicolet Avatar 360 FT-IR spectrometer using film KBr pellet techniques. 1 H and 13 C NMR spectra were recorded in CDCl 3 or CD 3 OD on a Bruker 400 spectrometer with tetramethylsilane as an internal standard. Chemical shifts are expressed in δ (ppm) units downfield from TMS. Mass spectra were recorded by a Bruker Dalton ESquire 3000 plus liquid chromatography-mass spectrum (direct injection). Optical rotations were measured with a Perkin-Elmer 341 automatic polarimeter. Diastereoselectivities and enantioselectivities were determined by chiral HPLC analysis using a Shimadzu LC-10AT VP series and a Shimadzu SPD-M10Avp photo diode array detector (190-370 nm) with a Chiralcel OJ-H column using n-hexane/i-PrOH (98:2, v/v) as a mobile phase. Flash column chromatography was carried out with silica gel (300-400 mesh). THF was distilled over sodium benzophenone ketyl under N 2 .
General
Procedure A: the synthesis of acrylic acid from aromatic aldehyde-Appropriate anhydride (300 mmol, 1.6 equiv.) was added to potassium carbonate (224 mmol, 1.2 equiv.) at 0 °C. After stirring for 5 min to mix up, appropriate aromatic aldehyde (186 mmol, 1.0 equiv.) was added. The mixture was heated to reflux for 12 h. After cooling with an ice bath, to the reaction mixture was added water and solid Na 2 CO 3 (30 g ). After the resultant yellow precipitate was filtered, the reaction mixture was acidified to pH 6.0 using concentrated HCl to afford acrylic acid as a solid. 
3-(4-
Fluorophenyl
General
Procedure B: the synthesis of propanoic acid derivative from acrylic acid by Pd/C-catalyzed reduction-A mixture of acrylic acid (55 mmol, 1.0 equiv.) and Pd/C (10%) in methanol (70 mL) was hydrogenated under 10 atm of hydrogen for 24 h. The catalyst was filtered off and the filtrate concentrated to afford propanoic acid, which was used in the next step as it was. An analytical sample of compound was obtained by flash column chromato-graphy on silica gel. [24] was synthesized according to the general procedure B. Colorless oil, yield: 90%. IR (film): ν max 3406, 2972, 2933, 1701, 1560, 1509, 1460, 1406, 1223 cm −1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 1.12 (d, J = 6.7 Hz, 3H, CH 3 ), 2.60 (dd, J = 13.0, 7.9 Hz, 1H, CH 2 CH), 2.66 (ddq, J = 7.9, 6.0, 6.7 Hz, CHCH 3 ), 2.99 (dd, J = 13.0, 6.0 Hz, 1H, CH 2 CH), 6.90-7.00 (m, 2H, Ar-H), 7.06-7.14 (m, 2H, Ar-H), 9 .80 (br s, 1H, COOH) ppm; 13 5.1.6. General Procedure C: the synthesis of indenone from propanoic acid derivative by F-C acylation-A mixture of the crude propanoic acid derivative (42.0 mmol, 1.0 equiv.) and polyphosphoric acid (400 mmol, 9.5 equiv.) was stirred at 80 °C for 12 hours. The resulting mixture was poured into ice water and extracted with EtOAc (30 mL × 3). The combined extracts were washed with a saturated aqueous NaHCO 3 (10 mL × 3) to remove the starting acids, and then washed with brine, dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography to afford indenone. [24] was synthesized according to the general procedure C, and purified by flash column chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1:40 
3-(4-Fluorophenyl)-2-methylpropanoic acid (33)-Compound 33

6-Fluoro-2-methyl-2,3-dihydroinden-1-one (34)-Compound 34
General
Procedure D: the synthesis of inden-3-yl acetate from indenone -To a solution of LDA or LHMDS (48.0 mmol, 2.0 equiv.) in anhydrous THF (100 mL) was added EtOAc (61.0 mmol, 2.5 equiv.) at −78 °C. The mixture was stirred at −78 °C for 30 min. To the resulting mixture was added dropwise a solution of indenone (24.0 mmol, 1.0 equiv.) in anhydrous THF (20 mL). The mixture was stirred at −78 °C for another 4 hr and then quenched with a saturated aqueous NH 4 Cl. The mixture was extracted with EtOAc (20 mL × 3). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. To the residue was added HOAc/H 2 SO 4 (10/1, 40 mL). After stirring for 4 hr at room temperature, the mixture was extracted with EtOAc (15 mL × 3). The combined extracts were washed successively with water, saturated NaHCO 3 , and brine, dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography on silica gel to afford inden-3-yl acetate. [24] was synthesized according to the general procedure D, and purified by flash column chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1:50 
Ethyl 2-(5-fluoro-2-methyl-1H-inden-3-yl)acetate (35)-Compound 35
5.1.10.
General Procedure E: the synthesis of indene derivative from appropriate inden-3-yl acetate-To a solution of indene-3-yl acetate 35 (1.3 mmol, 1.0 equiv.) in MeOH (4.0 mL) was added 2.5 N NaOMe (4.0 mmol, 3.0 equiv.) at room temperature to get an orange mixture. After stirring for 30 min, to the mixture was added appropriate aromatic aldehyde (1.3~2.0 mmol, 1.0~1.5 equiv.). The resulting mixture was refluxed at 80 °C for 4 h. After concentrated under reduced pressure, the residue was acidified with a 1N HCl solution to pH 4.0~6.0. After stirring for another 0.5 hr at room temperature, the mixture was extracted with EtOAc (15 mL × 3). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by flash chromatography to afford indene derivative. An analytical sample of compound was obtained by recrystallization.
(Z)-2-(1-Benzylidene-5-fluoro-2-methyl-1H-inden-3-yl) acetic acid (3)-
Compound 3 was synthesized according to the general procedure E, and purified by flash column chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1:3 4 Cl. The mixture was extracted with EtOAc (20 mL × 3). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and concentrated under reduced pressure. Then to the residue in MeOH (3 mL) was added 2N NaOH (2 mL). The mixture was stirring for 2 hr at 65 °C. After concentrated under reduced pressure, the residue was acidified with a 1N HCl solution to pH 6.0~7.0. The residue was purified by flash chromatography on silica gel (eluent: 1 
3-(5-Fluoro-2-methyl-1H-inden-3-yl)propanenitrile (39)-A solution of
compound 34 (300.0 mg, 1.8 mmol), and iso-propanol (0.7 mL, 9.0 mmol), and acrylonitrile (1.2 mL, 18.0 mmol) in THF (4 mL) was purged with argon for 20 min and cooled to 0 °C. A SmI 2 (5.4 mmol) solution in THF (54 mL) was added through transfer needle. After 5 min, the reaction was quenched with saturated aqueous Na 2 CO 3 (10 mL). The resulting mixture was extracted with Et 2 O (15 mL × 3). The combined organic phases were washed with brine, dried over anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure.
To the residue was added HOAc/H 2 SO 4 (10/1, 3.0 mL). After stirring for 4 hr at room temperature, the mixture was extracted with EtOAc (15 mL × 3). The combined extracts were washed successively with saturated NaHCO 3 and brine, dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography on silica gel (eluent: ethyl acetate: petroleum ether = 1:4) to afford compound 39 as a white solid (108 mg, 30% 13 13 hr at room temperature, the catalyst was filtered off and the mixture was acidified with a 6N HCl solution to pH 7.0, concentrated, extracted with EtOAc (20 mL × 3). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and concentration under reduced pressure. The residue was purified by flash chromatography on silica gel (eluent: petroleum ether) to afford compound 44 as white solid (511 mg, 62% [25] was synthesized according to the general procedure B. Ethyl 2-(5-isopropyl-2-methyl-1H-inden-3-yl) crystal structure of RXRα LBD in complex with antagonist LG100754 (Protein Data Bank code 3A9E) was used. The GLIDE GScore was used as docking score to rank the docking results. Visual inspection was done to pick the docked pose from the ranked results. Schrödinger's Maestro 6.5 was used to prepare Figure 5 .
2-(4-Fluorlbenzyl)butanoic acid (41)-Compound
2-Ethyl-6-fluoro-2,3-dihydro-1H-inden-1-one (42)-Compound
Ethyl-2-(2-ethyl-5-fluoro-1H-inden-3-yl)acetate (43)-Compound
(Z)-2-(2-Ethyl-5-fluoro-1-(4-isopropylbenzylidene)-1H-inden-3-yl)acetic acid (21)-Compound
2-Methyl-3-p-tolylpropanoic acid (48b)-Compound
3-(4-Methoxyphenyl)-2-methylpropanoic acid (48c)-Compound 48c
Highlights
• 28 new Sulindac analogs as modulators of tRXRa-dependent AKT activation were synthesized.
• Binding assay was used to test the 28 compounds for SAR study.
• A new scaffold was found with improved biological properties. Structure and RXRα binding activity of Sulindac and K-80003 Scaffold for the SAR study Structure of E-isomer 30 Inhibition of Gal4-RXRα-LBD activit by 30. HCT116 cells transfected with pG5 luciferase reporter vector and pGAL4-RXRα-LBD expression vector (50ng/well) were incubated with or without 9-cis-RA (10 −7 M) in the presence or absence of the indicated concentrations of 2 or 30 for 12 hr. Luciferase activities were measured using the Dual-Luciferase Assay System Kit. For comparison, the effect of BI-1003 (1 μM) was shown. Results of the Claisen-Schmidt reactions 
